Sagar Lonial - Net Worth and Insider Trading

Sagar Lonial Net Worth

The estimated net worth of Sagar Lonial is at least $3 Million dollars as of 2024-11-05. Sagar Lonial is the Director of TG Therapeutics Inc and owns about 105,195 shares of TG Therapeutics Inc (TGTX) stock worth over $3 Million. Details can be seen in Sagar Lonial's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sagar Lonial has not made any transactions after 2024-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sagar Lonial

To

Sagar Lonial Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sagar Lonial owns 1 companies in total, including TG Therapeutics Inc (TGTX) .

Click here to see the complete history of Sagar Lonial’s form 4 insider trades.

Insider Ownership Summary of Sagar Lonial

Ticker Comapny Transaction Date Type of Owner
TGTX TG Therapeutics Inc 2024-06-20 director

Sagar Lonial Latest Holdings Summary

Sagar Lonial currently owns a total of 1 stock. Sagar Lonial owns 105,195 shares of TG Therapeutics Inc (TGTX) as of June 20, 2024, with a value of $3 Million.

Latest Holdings of Sagar Lonial

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TGTX TG Therapeutics Inc 2024-06-20 105,195 24.27 2,553,083

Holding Weightings of Sagar Lonial


Sagar Lonial Form 4 Trading Tracker

According to the SEC Form 4 filings, Sagar Lonial has made a total of 3 transactions in TG Therapeutics Inc (TGTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in TG Therapeutics Inc is the sale of 25,933 shares on June 20, 2024, which brought Sagar Lonial around $432,822.

Insider Trading History of Sagar Lonial

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sagar Lonial Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sagar Lonial Ownership Network

Ownership Network List of Sagar Lonial

No Data

Ownership Network Relation of Sagar Lonial

Insider Network Chart

Sagar Lonial Owned Company Details

What does TG Therapeutics Inc do?

Who are the key executives at TG Therapeutics Inc?

Sagar Lonial is the director of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .

TG Therapeutics Inc (TGTX) Insider Trades Summary

Over the past 18 months, Sagar Lonial made 3 insider transaction in TG Therapeutics Inc (TGTX) with a net sale of 65,787. Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 121,514 shares made by Sean A Power , a net sale of 39,500 shares made by Laurence N Charney , and a net purchase of 100,000 shares made by Michael S Weiss .

In summary, during the past 3 months, insiders sold 0 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 226,801 shares of TG Therapeutics Inc (TGTX) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 126,801 shares.

TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TG Therapeutics Inc Insider Transactions

No Available Data

Sagar Lonial Mailing Address

Above is the net worth, insider trading, and ownership report for Sagar Lonial. You might contact Sagar Lonial via mailing address: C/o Tg Therapeutics, Inc., 2 Gansevoort Street, 9th Floor, New York Ny 10014.